7 reports

Summary Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer.It offers lead products such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxcolorectal, a prognostic...

  • Healthcare
  • Bladder Cancer
  • Gastric Cancer
  • New Zealand
  • Medical Devices Sales

Summary Bioprognos SL (Bioprognos) is a cancer diagnostics company that develops non-invasive and accurate diagnostics solutions.The company’s pipeline products include OncoBREAST Dx, OncoLUNG Dx, OncoOVARIAN Dx, OncoPROSTATE Dx, OncoCUP Dx, OncoLIVER Dx, OncoNECK Dx, OncoBLADDER Dx, and OncoCOLON Dx. It offers IOTA’s...

  • Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Gastric Cancer
  • Cancer Diagnostics
  • Clinical Trial
  • Europe
  • Medical Devices Sales

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017 Summary Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, stomach pain, vomiting, weight loss that is unintentional, feeling...

  • Gastric Cancer
  • Esophageal Cancer
  • Prescription Drug Sales
  • Biologics Penetration Rate

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies Summary Gastric cancer is characterized by the formation of malignant cells in the inner lining of the stomach, and is the fifth most common cancer globally. Due to its indolent nature it...

  • Gastric Cancer
  • Therapy
  • World
  • APAC
  • Mortality Rate
  • Cancer Mortality

Summary Miraculins Inc. (Miraculins) is a biotechnology company that offers therapeutic products. The company acquires, develops and commercializes risk assessment tests, and non invasive diagnostic tests for the healthcare market. It provides discovery and validation of cancer biomarkers for development of diagnostic tools and...

  • Diagnostics
  • Clinical Trial
  • Gastric Cancer
  • Pancreatic Cancer
  • Colorectal Cancer
  • Canada
  • United States
  • China
  • Prescriptions Filled
  • In Store Traffic

Frontier Pharma: Gastric Cancer - Early Stage Pipeline Innovation Shows Shift Towards Targeted mAbs Summary Gastric cancer is the fifth most common cancer globally, and due to its indolent nature remains one of the most common causes of cancer-related death worldwide. Such a poor outlook, particularly for patients...

  • Gastric Cancer
  • United States
  • World
  • Europe
  • Japan
  • Drug Approval
  • Medical Technology Density

Summary Oryzon Genomics S.A. (Oryzon) is a clinical stage biopharmaceutical company that offers development of epigenetics-based therapeutics. The company offers epigenetics, a regulatory system that controls gene expression without affecting the makeup of the genes themselves and provides regulation of gene transcription that...

  • Genomics
  • Gastric Cancer
  • Prostate Cancer
  • Diagnostics
  • Stomach Cancer
  • Spain